≪英文≫

Advanced prostate cancer discovered with cancerous peritonitis: Case report.

Kurahashi R, Fukushima Y, Motoshima T, Murakami Y, Yatsuda J, Yamaguchi T, Tanoue K, Sugiyama Y, Nishi K, Kamba T.

Urol Case Rep. 2018 Oct 22;22:31-33.

 

Clinical Outcomes in Patients With Metastatic Papillary Renal-Cell Carcinoma: A Multi-Institutional Study in Japan.

Ito K, Mikami S, Tatsugami K, Masumori N, Shinohara N, Kondo T, Nakanishi S, Nagashima Y, Eto M, Kamba T, Kuroda N, Tomita Y, Matsuyama H, Onishi T, Tsushima T, Nakazawa H, Oya M, Ozono S, Naito S, Asano T.

Clin Genitourin Cancer. 2018 Dec;16(6):e1201-e1214.

 

Intravesical prostatic protrusion is not always the same shape: Evaluation by preoperative cystoscopy and outcome in HoLEP.

Ito K, Takashima Y, Akamatsu S, Terada N, Kobayashi T, Yamasaki T, Inoue T, Kamba T, Ogawa O, Negoro H.

Neurourol Urodyn. 2018 Sep;37(7):2160-2166.

 

A pilot study of highly hypofractionated intensity-modulated radiation therapy over 3 weeks for localized prostate cancer.

Nakamura K, Ikeda I, Inokuchi H, Takayama K, Inoue T, Kamba T, Ogawa O, Hiraoka M, Mizowaki T.

J Radiat Res. 2018 Sep 1;59(5):656-663.

 

A family case with germline TSC1 and mtDNA mutations developing bilateral eosinophilic chromophobe renal cell carcinomas without other typical phenotype of tuberous sclerosis.

Sakamoto H, Yamasaki T, Sumiyoshi T, Utsunomiya N, Takeda M, Kamba T, Nakamura E, Ogawa O.

J Clin Pathol. 2018 Oct;71(10):936-943.

 

Folliculin Regulates Osteoclastogenesis Through Metabolic Regulation.

Baba M, Endoh M, Ma W, Toyama H, Hirayama A, Nishikawa K, Takubo K, Hano H, Hasumi H, Umemoto T, Hashimoto M, Irie N, Esumi C, Kataoka M, Nakagata N, Soga T, Yao M, Kamba T, Minami T, Ishii M, Suda T.

J Bone Miner Res. 2018 Oct;33(10):1785-1798.

 

Role of bone scan index in the prognosis and effects of therapy on prostate cancer with bone metastasis: Study design and rationale for the multicenter Prostatic Cancer Registry of Standard Hormonal and Chemotherapy Using BoneScan Index (PROSTAT-BSI) study.

Nakajima K, Kaneko G, Takahashi S, Matsuyama H, Shiina H, Ichikawa T, Horikoshi H, Hashine K, Sugiyama Y, Miyao T, Kamiyama M, Harada K, Ito A, Mizokami A; PROSTAT-BSI Investigators.

Int J Urol. 2018 May;25(5):492-499.

 

CD169-positive sinus macrophages in the lymph nodes determine bladder cancer prognosis.

Asano T, Ohnishi K, Shiota T, Motoshima T, Sugiyama Y, Yatsuda J, Kamba T, Ishizaka K, Komohara Y.

Cancer Sci. 2018 May;109(5):1723-1730.

 

Impact of a robotic surgical system on treatment choice for men with clinically organ-confined prostate cancer.

Kobayashi T, Kanao K, Araki M, Terada N, Kobayashi Y, Sawada A, Inoue T, Ebara S, Watanabe T, Kamba T, Sumitomo M, Nasu Y, Ogawa O.

Int J Clin Oncol. 2018 Apr;23(2):347-352.

 

Phenotypical change of tumor-associated macrophages in metastatic lesions of clear cell renal cell carcinoma.

Motoshima T, Miura Y, Wakigami N, Kusada N, Takano T, Inoshita N, Okaneya T, Sugiyama Y, Kamba T, Takeya M, Komohara Y.

Med Mol Morphol. 2018 Mar;51(1):57-63.

 

CD163-positive cancer cells are potentially associated with high malignant potential in clear cell renal cell carcinoma.

Ma C, Horlad H, Ohnishi K, Nakagawa T, Yamada S, Kitada S, Motoshima T, Kamba T, Nakayama T, Fujimoto N, Takeya M, Komohara Y.

Med Mol Morphol. 2018 Mar;51(1):13-20.

 

Decreased acute toxicities of intensity-modulated radiation therapy for localized prostate cancer with prostate-based versus bone-based image guidance.

Nakamura K, Mizowaki T, Inokuchi H, Ikeda I, Inoue T, Kamba T, Ogawa O, Hiraoka M.

Int J Clin Oncol. 2018 Feb;23(1):158-164.

 

The usefulness of testosterone administration in identifying false-positive elevation of serum human chorionic gonadotropin in patients with germ cell tumor.

Takizawa A, Kawai K, Kawahara T, Kojima T, Maruyama S, Shinohara N, Akamatsu S, Kamba T, Nakamura T, Ukimura O, Jikuya R, Kishida T, Kakimoto K, Nishimura K, Harabayashi T, Nagamori S, Yamashita S, Arai Y, Sawada Y, Sekido N, Kinoshita H, Matsuda T, Nakagawa T, Homma Y, Nishiyama H.

J Cancer Res Clin Oncol. 2018 Jan;144(1):109-115.

 

Bladder cancer-associated cancer-testis antigen-derived long peptides encompassing both CTL and promiscuous HLA class II-restricted Th cell epitopes induced CD4₊ T cells expressing converged T-cell receptor genes in vitro.

Tsuruta M, Ueda S, Yew PY, Fukuda I, Yoshimura S, Kishi H, Hamana H, Hirayama M, Yatsuda J, Irie A, Senju S, Yuba E, Kamba T, Eto M, Nakayama H, Nishimura Y.

Oncoimmunology. 2018 Jan 5;7(4):e1415687

 

≪和文≫

成長ホルモン産生下垂体腫瘍による先端巨大症を合併したアンドロゲン産生副腎腺腫の１例

前原遼, 今川大輔，村上洋嗣, 河野吉昭，山口隆大, 神波大己，江藤正俊

西日泌尿. 2018;80(12):663-668.

 

実臨床に有用な後腹膜腫瘍の特徴　−第19回九州泌尿器科共同研究　九州沖縄地区における後腹膜腫瘍の実態調査サブ解析−

藤本直浩, 守屋良介, 岩隈景子, 久保達彦, 久岡正典, 野口満, 有働和馬, 内藤誠二, 江藤正俊, 横溝晃, 三股浩光, 澁谷忠正, 賀本敏行, 分田裕順, 井川掌, 西原聖顕, 酒井英樹, 竹原浩介, 計屋知彰, 中川昌之, 山根隆史, 神波大己, 河野吉昭, 斎藤誠一, 安次嶺聡, 大城吉則, 田中正利, 古屋隆三郎, 石井龍

西日泌尿. 2018;80(3):91-96.

 

ロボット支援腹腔鏡下根治的前立腺全摘除術を施行した巨大前立腺Stromal tumor of uncertain malignant potential (STUMP) の１例

今川大輔, 矢津田旬二, 村上洋嗣, 山口隆大, 田上憲一郎, 杉山豊, 西一彦, 神波大己, 江藤正俊

西日泌尿. 2018;80(1):19-23.

 

巨大な嚢胞性副腎褐色細胞腫の１例

穴見俊樹, 倉橋竜磨, 矢津田旬二, 田上憲一郎, 神波大己, 高橋渡

西日泌尿. 2018;80(1):12-18.